These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

439 related items for PubMed ID: 18279751

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Intravenous levetiracetam in Thai children and adolescents with status epilepticus and acute repetitive seizures.
    Khongkhatithum C, Thampratankul L, Wiwattanadittakul N, Visudtibhan A.
    Eur J Paediatr Neurol; 2015 Jul; 19(4):429-34. PubMed ID: 25800343
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures.
    Piña-Garza JE, Nordli DR, Rating D, Yang H, Schiemann-Delgado J, Duncan B, Levetiracetam N01009 Study Group.
    Epilepsia; 2009 May; 50(5):1141-9. PubMed ID: 19243423
    [Abstract] [Full Text] [Related]

  • 27. Intravenous levetiracetam terminates refractory status epilepticus in two patients with migrating partial seizures in infancy.
    Cilio MR, Bianchi R, Balestri M, Onofri A, Giovannini S, Di Capua M, Vigevano F.
    Epilepsy Res; 2009 Sep; 86(1):66-71. PubMed ID: 19520548
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Efficacy and tolerability of high oral doses of levetiracetam in children with epilepsy.
    Obeid M, Pong AW.
    Epilepsy Res; 2010 Sep; 91(1):101-5. PubMed ID: 20663645
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Levetiracetam during 1-year follow-up in children, adolescents, and young adults with refractory epilepsy.
    Coppola G, Mangano S, Tortorella G, Pelliccia A, Fels A, Romano A, Nardello R, Habetswallner F, Licciardi F, Operto FF, Pascotto A.
    Epilepsy Res; 2004 Mar; 59(1):35-42. PubMed ID: 15135165
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Levetiracetam in children with refractory status epilepticus.
    Gallentine WB, Hunnicutt AS, Husain AM.
    Epilepsy Behav; 2009 Jan; 14(1):215-8. PubMed ID: 18926926
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Levetiracetam in a broad population of patients with refractory epilepsy: interim results of the international SKATE trial.
    Genton P, Sadzot B, Fejerman N, Peltola J, Despland PA, Steinhoff B, Rektor I, Wroe S, Maubrey MC, Vandervelden C, van Hammée G, Schlit AF, van Paesschen W.
    Acta Neurol Scand; 2006 Jun; 113(6):387-94. PubMed ID: 16674605
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Levetiracetam in juvenile myoclonic epilepsy: long-term efficacy in newly diagnosed adolescents.
    Verrotti A, Cerminara C, Coppola G, Franzoni E, Parisi P, Iannetti P, Aloisi P, Tozzi E, Cusmai R, Vigevano F, Chiarelli F, Curatolo P.
    Dev Med Child Neurol; 2008 Jan; 50(1):29-32. PubMed ID: 18173626
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.